(Q24244843)

1

0 references

R Garg

2

0 references

R Nelson

3

0 references

A Loza

4

0 references

T Novak

5

0 references

J Hansen

Cochrane Database of Systematic Reviews

6

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

Quebec to report on Clostridium difficile in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Diagnosis and treatment of Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Severe Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clinical practice. Antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clinical and laboratory observations in Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clostridium difficile: clinical considerations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Treatment of Clostridium difficile associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study. The Swedish CDAD Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004610.PUB2

7 January 2021